Sigma-Aldrich to Acquire JRH Biosciences to Broaden Life Science Capabilities

21-Jan-2005

Sigma-Aldrich Corporation announced that it has signed a definitive agreement to acquire the JRH Biosciences division (JRH) of CSL Limited, for $370 million in cash, subject to normal closing adjustments. JRH is a leading global supplier of cell culture and sera products to the biopharmaceutical industry with 2004 sales of approximately $150 million, which are expected to increase by approximately 10% in 2005. As much as ten months of JRH's operating results will be added to Sigma-Aldrich's performance in 2005 depending on the closing date for the transaction.

JRH is headquartered in Lenexa, Kansas, and has major manufacturing facilities in the United States, Europe and Australia and serum collection and processing centers in the United States and Australia. The company's product lines include sera, cell culture media used in the production of therapeutic proteins, reagent growth factors and biological material containers. JRH has approximately 400 employees.

The transaction has been approved by the boards of directors of both companies and, subject to regulatory approvals and other customary terms and conditions, is expected to close in the first quarter of 2005.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content

Topic world Cell culture technology

Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.

2 products
5+ whitepaper
2 brochures
View topic world

Topic world Cell culture technology

Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.

2 products
5+ whitepaper
2 brochures